Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The dig might have uncovered some of the earliest victims of the Black Death, and other tantalizing clues about medieval life in the citadel. The Chapel Royal of St Peter ad Vincula at the Tower of ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

Part of the Tower of London has been closed following reports of criminal damage to a display case containing the Imperial State Crown, part of the Crown Jewels. Police said four protesters had been ...

Four people arrested after civil-resistance group Take Back Power protest against inequality in the UK Part of the Tower of London was temporarily closed to visitors on Saturday after food was thrown ...

HANOI, Dec 11 (Reuters) - Industrial plants in the Vietnamese capital of Hanoi have come under renewed pressure to scale back their operations as authorities respond to a week of heavy and hazardous ...

Users can note which content they would like to view more frequently. Instagram is handing users some control in deciding what content they see. The social media giant is allowing users to have a say ...